Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-663-8 | CAS number: 67-66-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
No valid study on the irritating potential to the skin and eyes has been found. However, the available data give evidence that chloroform is an irritant to skin and eyes. Valid studies on the inhalation toxicity of chloroform demonstrate that an irritation of the respiratory tract is induced by subacute, subchronic or chronic inhalation exposure to the substance at doses above those inducing adverse systemic effects.
Key value for chemical safety assessment
Skin irritation / corrosion
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Eye irritation
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Additional information
Skin irritation
The skin irritation potential of chloroform was tested in female New Zealand rabbits and the skin reaction was evaluated according to Draize’s method (Duprat et al. 1976). A single application of pure chloroform (duration and extent of occlusion were not documented) resulted in moderate to severe erythema and moderate to severe oedema. The primary dermal irritation index of chloroform was 5.6 on a scale ranging from 0 to 8. Chloroform was classified as a severe skin irritant in the test. No corrosive effects of chloroform to the rabbit skin were mentioned in the study. Another skin irritation test was carried out with chloroform in which the substance was either applied frequently to the uncovered ear of three rabbits or a cotton pad soaked with chloroform was applied to the shaved skin of three rabbits for 24 hours (Torkelson et al. 1976). The prolonged dermal application of the soaked pads resulted in slight hyperaemia with moderate necrosis and a resulting eschar formation. Healing appeared to be delayed on these sites.
The available data give sufficient evidence that chloroform should be considered as being irritating to the skin. In contrast, no evidence of corrosivity of chloroform to the skin was found.
Eye irritation
An eye irritation test with chloroform was performed and an evaluation of the effects was done according to Draize's method with six female New Zealand rabbits (Duprat et al. 1976). Instillation of pure, liquid chloroform led to severe irritation and lesions of the conjunctivae with occurrence of purulent corneal discharge. Other effects included corneal inflammation. Recovery from these ocular effects took 2 to 3 weeks for most animals, except for one animal which still had corneal opacity after 3 weeks (Duprat et al. 1976). Liquid chloroform was instilled into the eye of three rabbits, with and without washing of the eye after treatment. Chloroform was a slight irritant to the conjunctiva, which was reversible after one week. In addition, slight but irreversible corneal injury occurred as evidenced by staining with fluorescein. A purulent exudate occurred for two or more days after treatment (Torkelson et al. 1976). In conclusion, chloroform was found to be irritating to the rabbit's eye.
The available studies on the eye irritation potential of chloroform give sufficient evidence that the substance has to be considered as a severe eye irritant. The studies also reported corneal effects that seemed to be not fully reversible after three weeks of observation. However, there is not sufficient evidence of severe damage to the eye induced by exposure to chloroform.
Effects in the nasal passage
Irritation of the respiratory tract induced by chloroform vapours was reported from acute (Méry et al. 1994), sub-acute (Larson et al. 1996), sub-chronic (Templin et al. 1996) and chronic (Yamamoto et al. 2002) inhalation studies. Effects included nasal lesions and cell proliferation in the olfactory epithelium and the nasal passage. Cell proliferation was observed in the nose (ethmoid region) of male F-344 rats following inhalation exposure at 10 mg/m3 for 6 h/day for 4 days, however, at 50 mg/m3 only minimal to mild lesions were seen and the effects were transient (Templin et al. 1996b). A late atrophy was present not only in the areas of early cell proliferation but in the whole ethmoid region of the nasal cavity after 13 weeks of exposure. The atrophy was minimal at exposure levels of 10 mg/m3 and more distinct at higher exposure concentrations. Following exposure to 50 mg/m3 for 6 h/day for 7 consecutive days, male F-344 rats had lesions in nasal turbinates, including increased cell proliferation in central, proximal, and distal regions of the first endoturbinate, and histological changes in the central turbinate bone (Larson et al., 1994a; Méry et al., 1994). Cell proliferation was also seen in the nasal turbinates of female B6C3F1 mice exposed at 10 mg/m3, but not at 1.5 mg/m3, for 6 h/day for four consecutive days (Larson et al., 1996). Increased cell proliferation was detected in the first endoturbinate of the nasal passage in female B6C3F1 mice exposed to 50 mg chloroform/m3, 6 h/day, for 7 consecutive days (Méry et al., 1994) but no microscopic damage was seen in the nasal passages of female B6C3F1 mice exposed to up to 1500 mg/m3 for 6 h/day for 7 consecutive days. Thus, it appears that the notable effects of chloroform on the respiratory tract occur with exposure concentrations of 50 mg/m3.
Effects on skin irritation/corrosion: irritating
Effects on eye irritation: irritating
Effect level: empty Endpoint conclusion: Adverse effect observed
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live1